Windtree Therapeutics, Inc.

WINT | NASDAQ | 1 Sledující

$0.82

3.81%

$0.03

Sledovat

Overview Metrics Financials

Company Quality

Profitability Score

17/100

Solvency Score

45/100

Dividends

Dividends data currently unavailable.

Earnings

8/18/2025

in 88 days

Revenue est.

EPS est.

My Notes

You haven't added any notes for this stock yet. Use this space to record your insights or strategies.

Profile

Healthcare

Sektor

Biotechnology

Průmysl

Mr. Jed A. Latkin

CEO

Zaměstnanci

Warrington

Centrála

Země

Key Metrics TTM

Valuation

Market cap.

$2.9M

Enterprise Value

$3.1M

Price to Earnings

-0.0004

Price to Sales

64.27

Price to Book

0.0083

Price to Cash Flow

-0.19

Profitability

Return on Assets

-77.52%

Return on Equity

-320.56%

Return on Invested Capital

-108.17%

Gross Margin

46.67%

Operating Margin

-48,297.80%

Net Margin

-46,108.90%

Liquidity

Quick Ratio

0.25

Current Ratio

0.25

Cash Ratio

0.18

Inventory Turnover

0.00

Asset Turnover

0.0017

Total Liabilities

$15M

Solvency

Debt to Assets

0.05

Debt to Equity

N/A

Interest Coverage

-107.6

Equity Ratio

0.42

Long-term Debt to Cap.

0.33

Altman Z-Score

-46.04

Performance

Earnings Waterfall

Debt level and coverage

Earnings

Feed

There are no posts to show right now.